Free Trial
OTCMKTS:PVBK

Pacific Valley Bancorp (PVBK) Stock Price, News & Analysis

Pacific Valley Bancorp logo
$10.40 0.00 (0.00%)
As of 07/3/2025

About Pacific Valley Bancorp Stock (OTCMKTS:PVBK)

Key Stats

Today's Range
$10.40
$10.40
50-Day Range
$9.64
$10.40
52-Week Range
$8.75
$10.40
Volume
N/A
Average Volume
2,224 shs
Market Capitalization
$51.48 million
P/E Ratio
12.24
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PVBK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pacific Valley Bancorp and its competitors with MarketBeat's FREE daily newsletter.

PVBK Stock News Headlines

Pacific Valley Bancorp (PVBK) - Yahoo Finance
PVBK Pacific Valley Bancorp
Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.
See More Headlines

PVBK Stock Analysis - Frequently Asked Questions

Pacific Valley Bancorp's stock was trading at $9.50 at the start of the year. Since then, PVBK stock has increased by 9.5% and is now trading at $10.40.

Pacific Valley Bancorp (OTCMKTS:PVBK) posted its earnings results on Tuesday, April, 29th. The financial services provider reported $0.19 earnings per share for the quarter. The financial services provider had revenue of $5.16 million for the quarter.

Shares of PVBK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pacific Valley Bancorp investors own include American River Bankshares (AMRB), Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX) and Aldeyra Therapeutics (ALDX).

Company Calendar

Last Earnings
4/29/2025
Today
7/07/2025
Next Earnings (Estimated)
7/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Finance
Industry
BANKS - SOUTHWEST
Sub-Industry
N/A
Current Symbol
OTCMKTS:PVBK
CIK
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
12.24
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$4.42 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$30.26 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$51.48 million
Optionable
Not Optionable
Beta
0.20
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (OTCMKTS:PVBK) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners